Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis.
Prediction of disability progression in fingolimod-treated patients.
Experimental and therapeutic opportunities for stem cells in multiple sclerosis.
The relationship between muscle pain and fatigue.
Literature Commentary.
The Efficacy of Primidone in Reducing Severe Cerebellar Tremors in Patients With Multiple Sclerosis.
Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis.
Most Scottish neurologists do not apply the 2010 McDonald criteria when diagnosing multiple sclerosis.
[Cognitive disorders in multiple sclerosis: correlations between neuropsychological, neurophysiological and neuroimaging characteristics.]
Intrathecal baclofen in multiple sclerosis.
Multiple sclerosis, an unlikely cause of chronic cerebrospinal venous insufficiency: retrospective analysis of catheter venography.
Real-World Use of Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis: A Retrospective Study Using the National Multiple Sclerosis Registry in Kuwait.
Redox processes in neurodegenerative disease involving reactive oxygen species.
Long-term endurance exercise improves aerobic capacity in patients with relapsing-remitting Multiple Sclerosis: Impact of baseline fatigue.
Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound.
The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania.
Neuroimaging biomarkers of neurodegenerative diseases and dementia.
Seronegative NMO: A sensitive AQP4 antibody test clarifies clinical features and next challenges.
Unusual Manifestations of Pediatric Neuromyelitis Optica.
Assessing the Correlation between Grey and White Matter Damage with Motor and Cognitive Impairment in Multiple Sclerosis Patients.
[Hypomyelination with atrophy of the basal ganglia and cerebellum. Contribution of two new cases to a recently reported entity].
Quantitative assessment of finger motor impairment in multiple sclerosis.
Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis (MS-STAT)
Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction.
Pages
« first
‹ previous
…
388
389
390
391
392
393
394
395
396
…
next ›
last »